Sanela Bilic

Sanela Bilic

UNVERIFIED PROFILE

Are you Sanela Bilic?   Register this Author

Register author
Sanela Bilic

Sanela Bilic

Publications by authors named "Sanela Bilic"

Are you Sanela Bilic?   Register this Author

17Publications

630Reads

44Profile Views

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.

Mod Pathol 2019 Dec 25;32(12):1834-1846. Epub 2019 Jun 25.

Department of Pathology and Laboratory Medicine, University of Calgary, Foothills Medical Center, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0302-0DOI Listing
December 2019

Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach.

J Clin Pharmacol 2017 Oct;57 Suppl 10:S105-S115

D3 Medicine, a Certara USA Company, Parsippany, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.908DOI Listing
October 2017

New Insights in Tissue Distribution, Metabolism, and Excretion of [3H]-Labeled Antibody Maytansinoid Conjugates in Female Tumor-Bearing Nude Rats.

Drug Metab Dispos 2016 07 27;44(7):897-910. Epub 2016 Apr 27.

Novartis Institutes for Biomedical Research, Drug Metabolism and Pharmacokinetics, Basel, Switzerland (M.W, B.R., T.W., J.B., M.S., T.M., G.P., O.H., W.E., C.L.); and Translational Clinical Oncology, East Hannover, New Jersey (S.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.115.069021DOI Listing
July 2016

Unexpected hepatotoxicity in a phase I study of TAS266, a novel tetravalent agonistic Nanobody® targeting the DR5 receptor.

Cancer Chemother Pharmacol 2015 May 27;75(5):887-95. Epub 2015 Feb 27.

South Texas Accelerated Research Therapeutics, 4383 Medical Drive, Suite 4021, San Antonio, TX, 78229, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-015-2712-0
Publisher Site
http://dx.doi.org/10.1007/s00280-015-2712-0DOI Listing
May 2015

Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors.

Invest New Drugs 2014 Feb 16;32(1):135-44. Epub 2013 Apr 16.

Huntsman Cancer Institute, Division of Medical Oncology, University of Utah, 2000 Circle of Hope Drive, Suite 3380, Salt Lake City, UT, 84112, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-9952-9DOI Listing
February 2014

Conference report: hot topics in antibody-drug conjugate development.

Bioanalysis 2013 Dec;5(24):2989-93

Novartis Pharmaceuticals, Clinical Pharmacology, Oncology Business Unit, East Hanover, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/bio.13.276DOI Listing
December 2013

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma.

Br J Haematol 2012 Oct 4;159(1):58-66. Epub 2012 Aug 4.

Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09251.xDOI Listing
October 2012

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study.

BMC Clin Pharmacol 2008 Mar 31;8. Epub 2008 Mar 31.

Department of Haematology and Bone Marrow Transplantation, The Alfred Hospital, Prahan, Victoria, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6904-8-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330021PMC
March 2008

Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.

Antimicrob Agents Chemother 2007 May 5;51(5):1822-6. Epub 2007 Feb 5.

Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, 317 Hochstetter Hall, Amherst, NY 14260, USA.

View Article

Download full-text PDF

Source
http://aac.asm.org/content/51/5/1822.full.pdf
Web Search
http://aac.asm.org/cgi/doi/10.1128/AAC.00570-06
Publisher Site
http://dx.doi.org/10.1128/AAC.00570-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855557PMC
May 2007